Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention

Abstract Although tuberculosis (TB) is an infectious disease, the progression of the disease following Mycobacterium tuberculosis (MTB) infection is closely associated with the host's immune response. In this review, a comprehensive analysis of TB prevention, diagnosis, and treatment was conduc...

Full description

Bibliographic Details
Main Authors: Li Zhuang, Ling Yang, Linsheng Li, Zhaoyang Ye, Wenping Gong
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.419
_version_ 1797347143612104704
author Li Zhuang
Ling Yang
Linsheng Li
Zhaoyang Ye
Wenping Gong
author_facet Li Zhuang
Ling Yang
Linsheng Li
Zhaoyang Ye
Wenping Gong
author_sort Li Zhuang
collection DOAJ
description Abstract Although tuberculosis (TB) is an infectious disease, the progression of the disease following Mycobacterium tuberculosis (MTB) infection is closely associated with the host's immune response. In this review, a comprehensive analysis of TB prevention, diagnosis, and treatment was conducted from an immunological perspective. First, we delved into the host's immune response mechanisms against MTB infection as well as the immune evasion mechanisms of the bacteria. Addressing the challenges currently faced in TB diagnosis and treatment, we also emphasized the importance of protein, genetic, and immunological biomarkers, aiming to provide new insights for early and personalized diagnosis and treatment of TB. Building upon this foundation, we further discussed intervention strategies involving chemical and immunological treatments for the increasingly critical issue of drug‐resistant TB and other forms of TB. Finally, we summarized TB prevention, diagnosis, and treatment challenges and put forward future perspectives. Overall, these findings provide valuable insights into the immunological aspects of TB and offer new directions toward achieving the WHO's goal of eradicating TB by 2035.
first_indexed 2024-03-08T11:43:25Z
format Article
id doaj.art-56ec79917c514935b70295f3406e59e6
institution Directory Open Access Journal
issn 2688-2663
language English
last_indexed 2024-03-08T11:43:25Z
publishDate 2024-01-01
publisher Wiley
record_format Article
series MedComm
spelling doaj.art-56ec79917c514935b70295f3406e59e62024-01-25T02:14:28ZengWileyMedComm2688-26632024-01-0151n/an/a10.1002/mco2.419Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic interventionLi Zhuang0Ling Yang1Linsheng Li2Zhaoyang Ye3Wenping Gong4Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment Senior Department of Tuberculosis, the Eighth Medical Center of PLA General Hospital Beijing ChinaSenior Department of Tuberculosis Hebei North University Zhangjiakou Hebei ChinaSenior Department of Tuberculosis Hebei North University Zhangjiakou Hebei ChinaSenior Department of Tuberculosis Hebei North University Zhangjiakou Hebei ChinaBeijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment Senior Department of Tuberculosis, the Eighth Medical Center of PLA General Hospital Beijing ChinaAbstract Although tuberculosis (TB) is an infectious disease, the progression of the disease following Mycobacterium tuberculosis (MTB) infection is closely associated with the host's immune response. In this review, a comprehensive analysis of TB prevention, diagnosis, and treatment was conducted from an immunological perspective. First, we delved into the host's immune response mechanisms against MTB infection as well as the immune evasion mechanisms of the bacteria. Addressing the challenges currently faced in TB diagnosis and treatment, we also emphasized the importance of protein, genetic, and immunological biomarkers, aiming to provide new insights for early and personalized diagnosis and treatment of TB. Building upon this foundation, we further discussed intervention strategies involving chemical and immunological treatments for the increasingly critical issue of drug‐resistant TB and other forms of TB. Finally, we summarized TB prevention, diagnosis, and treatment challenges and put forward future perspectives. Overall, these findings provide valuable insights into the immunological aspects of TB and offer new directions toward achieving the WHO's goal of eradicating TB by 2035.https://doi.org/10.1002/mco2.419biomarkersdiagnostic methodsimmune checkpointsimmune responsemycobacterium tuberculosis (MTB)therapeutic vaccines
spellingShingle Li Zhuang
Ling Yang
Linsheng Li
Zhaoyang Ye
Wenping Gong
Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
MedComm
biomarkers
diagnostic methods
immune checkpoints
immune response
mycobacterium tuberculosis (MTB)
therapeutic vaccines
title Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
title_full Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
title_fullStr Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
title_full_unstemmed Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
title_short Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
title_sort mycobacterium tuberculosis immune response biomarkers and therapeutic intervention
topic biomarkers
diagnostic methods
immune checkpoints
immune response
mycobacterium tuberculosis (MTB)
therapeutic vaccines
url https://doi.org/10.1002/mco2.419
work_keys_str_mv AT lizhuang mycobacteriumtuberculosisimmuneresponsebiomarkersandtherapeuticintervention
AT lingyang mycobacteriumtuberculosisimmuneresponsebiomarkersandtherapeuticintervention
AT linshengli mycobacteriumtuberculosisimmuneresponsebiomarkersandtherapeuticintervention
AT zhaoyangye mycobacteriumtuberculosisimmuneresponsebiomarkersandtherapeuticintervention
AT wenpinggong mycobacteriumtuberculosisimmuneresponsebiomarkersandtherapeuticintervention